AnalystsYun ZhongYun Zhong's Stock Forecasts
AnalystsYun Zhong
Sectors:
Industries:
Analyst Ranking
Bottom 5%
#4976 out of 5184 analysts
Average Return
-9.39%
Win Rate
45%21 out of 47
Risk vs Reward
Poor
Good
Yun Zhong's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moonlake ImmunotherapeuticsMLTX | +126.64% | $7.17 | $16.25 | 2025-09-29 - 2026-01-28 | Buy |
Camp4 Therapeutics CorpCAMP | +101.01% | $1.99 | $4.00 | 2025-05-26 - 2026-01-28 | Buy |
Wave Life Sciences LtdWVE | +82.90% | $6.96 | $12.73 | 2025-06-22 - 2026-01-28 | Buy |
Passage Bio IncPASG | +77.74% | $6.38 | $11.34 | 2025-08-12 - 2026-01-28 | Buy |
Tectonic Therapeutic IncTECX | +77.07% | $9.42 | $16.68 | 2022-12-07 - 2023-12-07 | Strong Buy |
Yun Zhong Analyst Color
Get additional color on Yun Zhong's coverage of popular stocks
Yun Zhong's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sarepta Therapeutics IncSRPT | 6 | Buy | $34.00 | +59.55% | Maintains | 6 days ago |
Rezolute IncRZLT | 2 | Hold | $2.00 | -40.83% | Maintains | 21 days ago |
Wave Life Sciences LtdWVE | 3 | Buy | $33.00 | +159.23% | Maintains | 2 months ago |
Ascendis Pharma AASND | 3 | Buy | $220.00 | -1.10% | Reiterates | 2 months ago |
Keros Therapeutics IncKROS | 3 | Hold | $16.00 | -10.26% | Maintains | 3 months ago |
Opus Genetics IncIRD | 1 | Buy | $8.00 | +196.30% | Initiates Coverage On | 3 months ago |
Protagonist Therapeutics IncPTGX | 3 | Buy | $86.00 | +5.19% | Maintains | 3 months ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Buy | $18.00 | +10.77% | Maintains | 4 months ago |
Passage Bio IncPASG | 3 | Buy | $40.00 | +252.73% | Maintains | 6 months ago |
Sagimet Biosciences IncSGMT | 1 | Buy | $28.00 | +378.22% | Initiates Coverage On | 6 months ago |
Voyager Therapeutics IncVYGR | 1 | Buy | $8.00 | +101.51% | Maintains | 6 months ago |
Camp4 Therapeutics CorpCAMP | 1 | Buy | $8.00 | +100.00% | Initiates Coverage On | 8 months ago |
Rocket Pharmaceuticals IncRCKT | 2 | Buy | $32.00 | +793.85% | Reiterates | 8 months ago |
Anavex Life Sciences CorpAVXL | 2 | Strong Buy | $28.00 | N/A | Maintains | 3 years ago |
Amicus Therapeutics IncFOLD | 1 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $3.00 | N/A | Maintains | 3 years ago |
Tectonic Therapeutic IncTECX | 2 | Strong Buy | $48.00 | N/A | Upgrades | 3 years ago |
Applied Genetic Technologies CorpAGTC | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Renovacor IncRCOR | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Strong Buy | $75.00 | N/A | Maintains | 3 years ago |
Lenz Therapeutics IncLENZ | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 4 years ago |
Bluebird Bio IncBLUE | 2 | Hold | $700.00 | N/A | Downgrades | 5 years ago |
Uniqure NvQURE | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 5 years ago |
Cartesian Therapeutics IncRNAC | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Sio Gene Therapies IncSIOX | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 5 years ago |
Taysha Gene Therapies IncTSHA | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 5 years ago |
Mereo Biopharma Group PLCMREO | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 5 years ago |
Nightstar Therapeutics PLCNITE1 | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.